Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric carboxymaltose for iron-deficient non-anaemic patients with restless legs syndrome
2013-000574-30Phase 4Completed
- Sponsor
- CSL Vifor
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in restless legs syndrome (RLS) and iron deficiency anemia (IDA) comparing Ferric carboxymaltose with Placebo (2 arms). Started Jul 2013; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
restless legs syndrome (RLS)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2013-000574-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000574-30.